Canada Cobalt Launches “Re-2OX Unlocks”, Signs Deal For First Revenue Stream
Momentum Public Relations
Press Release: May 7, 2019
Canada Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (the “Company” or “Canada Cobalt”) is pleased to announce its first revenue stream from Re-2OX, the Company’s proprietary and environmentally friendly hydrometallurgical process that bypasses a traditional smelter for efficient extraction of cobalt, precious metals and base metals.
In 2018, led by adviser Dr. Ron Molnar and SGS Lakefield, Canada Cobalt became the first company in Canada’s Cobalt heartland during the electric vehicle revolution to produce a battery grade Cobalt sulphate test product from its own feed (Castle mine). Much broader plans for Re-2OX are now beginning to roll out, applicable to the Castle mine and beyond, starting with the Company’s “Re-2OX Unlocks” model aimed at using the proprietary Re-2OX process to help public and private companies unlock asset value through leading edge metallurgical and metal recovery solutions offered by Re-2OX. Canada Cobalt, which has initiated the patent process for Re-2OX (refer to April 30, 2019, news release), fully protects its intellectual Re-2OX property in the “Re-2OX Unlocks” program.
Marc Bamber, Canada Cobalt director, commented: “CCW’s ‘Re-2OX Unlocks’ is a powerful merging of technology with the 2020’s resource sector and the global trend toward mass electrification. It’s also an excellent example of how Re-2OX is a very adaptable process, technically, and can also be used in multiple ways to leverage value for shareholders. This first agreement with Global Energy Metals puts us on a big runway of opportunity while it heightens potential for GEMC at its promising cobalt-nickel-copper battery metal properties in Nevada.
“A very active second quarter is unfolding for Canada Cobalt,” Bamber continued. “Re-2OX is one of four key pillars of a very focused strategy that will also be powered by our unique underground access/Phase 2 drilling at the Castle mine, a simple but effective tailings program, and discovery potential at Castle East.”
Canada Cobalt Signs Agreement with Global Energy Metals
Canada Cobalt and Global Energy Metals (TSXV: GEMC) have entered into a non-binding Memorandum of Understanding (MOU) that allows for cobalt-nickel-copper-bearing mineralized material from the GEMC’s Lovelock mine and Treasure Box Property to be put through the Re-2OX Process in order to confirm efficient battery metal extraction and create a battery grade test product.
Canada Cobalt will supervise the program, protecting its intellectual property, and will be paid a $200,000 upfront first-stage Re-2OX fee, with costs related to sampling and lab work to be borne by GEMC (maximum $100,000). The companies may broaden their relationship.
Strategic Investment
Canada Cobalt will take an immediate equity position in GEMC, subscribing for 2,000,000 units at 7.5 cents per unit for a total investment of $150,000. Each unit will consist of one common share and one transferable common share purchase warrant. Each warrant will entitle Canada Cobalt to acquire one common share of GEMC at a price of 10 cents per share for a period of 36 months from the closing date, subject to an acceleration clause. The private placement is subject to the approval of the TSX Venture Exchange and securities will be subject to a four-month hold period from the time of closing.
CEO’s Comment on Deal
Frank Basa, President and CEO of Canada Cobalt, stated: “We are pleased enter into a strategic relationship with the Global Energy Metals team. We have a shared objective of advancing the metallurgical understanding of GEMC’s promising Nevada based battery metal assets using Re-2OX. The very adaptable Re-2OX Process has shown very high recovery rates for multiple metals and the ability to create a compound suitable for end-use in battery production.”
Mitchell Smith, CEO of Global Energy Metals, stated: “While the future of EV’s and other green technologies is promising, North America is highly import-reliant for those critical metals that are fueling the road to electrification. Partnering with Canada Cobalt Works and utilizing their Re-2OX Process is a crucial step in unlocking the potential Lovelock and Treasure Box provide for shareholder exposure to strategically important U.S-based battery mineral assets. Significantly, Re-2OX has allowed Canada Cobalt to become the first company in Canada’s cobalt heartland to produce a battery grade cobalt sulphate test product with nickel-manganese-cobalt (NMC) formulations in their pipeline.”
Qualified Person
The technical information in this news release was prepared under the supervision of Frank J. Basa, P.Eng., Canada Cobalt’s President and Chief Executive Officer, who is a member of Professional Engineers Ontario and a qualified person in accordance with National Instrument 43-101.
About Canada Cobalt Works Inc.
Canada Cobalt is focused on immediate and longer-term value drivers at its past producing Castle mine and adjoining land package in the historic Northern Ontario Silver-Cobalt district, Canada’s cobalt heartland since the start of the electric vehicle revolution. The Canada Cobalt “advantage” includes underground access at Castle, an innovative tailings program with a plan to recover silver, gold and cobalt, a recently installed pilot plant to produce gravity concentrates on site, a proprietary hydrometallurgical process known as Re-2OX, and exciting exploration discovery potential at Castle East.
“Frank J. Basa”
Frank J. Basa, P. Eng.
President and Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.
SOURCE Canada Cobalt Works Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2019/07/c5608.html
Contact:
Frank J. Basa, P.Eng., President and CEO, 1-819-797-4144
- Published in Canada Cobalt Works, Mining, News Home
Arctic Star Exploration Corp. Completes Spring Exploration Program at Diagras Property, Northwest Territories, Canada
Momentum Public Relations
Press Release: May 6, 2019
Arctic Star Exploration Corp. (TSXV: ADD) (FSE: 82A1) (“Arctic Star” or the “Company”) is pleased to announce that its Spring exploration program has been successfully completed at its 40% owned Diagras Property (“Diagras” or the “Property”) located in the Northwest Territories, Canada. Diagras totals 22,595 Hectares within 31 mineral claims with a total of 23 known kimberlites. The data from this ground geophysical program has been received and interpreted by our technical team and they report the work has generated compelling drill targets.
The exploration program consisted of ground Gravity, Magnetic and Electromagnetic (EM) surveys focused around historically identified kimberlites as well as other airborne geophysical anomalies with kimberlite like signatures.
Margret Lake Diamonds Inc is a contributing Joint Venture (the “Joint Venture”) between the Company, which acts as project operator and holds a 60% interest, and Arctic Star Exploration Corp. (TSX.V: ADD) which holds a 40% interest. Diagras is located in the prolific Lac de Gras diamond field, Northwest Territories, Canada just 35 km from the world-class Diavik diamond mine. The Property lies directly on trend with the Diavik deposits currently being mined by a joint venture between Rio Tinto and Dominion Diamond Diavik.
Detailed, modern ground geophysical techniques are being employed to define possible additional kimberlite(s) or kimberlite phases not identified by previous explorers, who did not utilize all these techniques. This exploration approach has been successful elsewhere with recent examples including the discoveries of additional diamondiferous kimberlite at the Kelvin and Faraday kimberlite complex (Kennady North project adjacent to the Gahcho Kue’ Diamond Mine). Investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on Diagras.
The work has been funded in part by significant grants from the Government of the Northwest Territories (GNWT) Mining Incentive Program (MIP). The Company would like to thank the GNWT for their support and recognition of the potential for this quality exploration program, the funding is limited and only granted to those projects judged most likely to bring benefit to the NWT. Our companies are grateful for their consideration.
The Joint Venture has conducted ground geophysical work over three spring seasons and now has enough drill targets to justify drill mobilization, planned for spring 2020. The Diagras project has an active Class ‘A’ Land Use Permit which includes drilling. The permit is good until December 2022 and has the ability for extension.
Table 1 Summary of 2019 Work and Drill Targets
Target
|
Gravity
(stations) |
Ohm Mapper
(line kilometers) |
Magnetics
(line kilometers) |
Drill testing
Planned |
Anne
|
X
|
X
|
X
|
|
Black Spruce
|
236
|
12.8
|
20.2
|
/
|
Dodi
|
X
|
X
|
18
|
|
Don
|
X
|
X
|
X
|
|
Drew
|
X
|
X
|
X
|
|
Emily
|
X
|
X
|
X
|
|
Finlay
|
168
|
X
|
X
|
|
George
|
X
|
X
|
X
|
|
Hanna
|
X
|
X
|
X
|
|
HL01
|
34
|
X
|
X
|
|
HL02
|
104
|
3.1
|
8.66
|
/
|
HL055
|
X
|
X
|
8.3
|
|
Jack Pine/Sequoia
|
253
|
9.94
|
39.02
|
/
|
Kong
|
178
|
5.6
|
18.72
|
/
|
Krista
|
X
|
X
|
12.6
|
|
Lindsey
|
X
|
X
|
11.6
|
|
Nadine
|
40
|
83.2
|
||
Naomi
|
126
|
7.7
|
16.43
|
|
Penelope (aka DG007)
|
169
|
5.8
|
15
|
/
|
Petra
|
72
|
7.8
|
63
|
|
Suzanne
|
199
|
16.1
|
18.55
|
/
|
Tabatha
|
253
|
9.94
|
39.02
|
/
|
Taz
|
X
|
X
|
11.6
|
Below is a review of some of the more promising targets generated from this work:
At the Black Spruce kimberlite, Monopros (a subsidiary of De Beers) discovered this kimberlite by drilling a distinct magnetic low in the early 1990’s. In the early 2000’s the property was optioned to Majescor, which drilled the edge of the magnetic kimberlite testing in part the EM anomaly. Our work in 2017 shows a series of gravity lows occur coincident and adjacent to the south of the known magnetic kimberlite phase. One of these gravity anomalies clearly breaks and disturbs a diabase dyke signature, which is a characteristic similar to many known Lac de Gras kimberlites. Results from this year, 2019, show a strong EM anomaly that is partly separate and partly coincident with the magnetic and gravity anomalies. The simplest explanation is that each geophysical signature, the Magnetic, the gravity and the EM represent different phases of the same kimberlite complex. Each phase can have totally different diamond grades and populations. The gravity and EM anomalies require separate drill testing. Three separate targets exist.
Figure 1. Ohm Mapper results for the Black Spruce Kimberlite. Colour image, EM data Magenta is less resistive. Contours Gravity data. 0.1mgal contours. Dotted blue outlines gravity targets, black outline magnetic signature. Note that they overlap but don’t coincide which may indicate separate kimberlite phases. Dots are previous drill holes targeting the magnetic anomaly. The black dots Majescor holes
To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/4806/44557_10a1724c14e86a64_002full.jpg
At the Jack Pine kimberlite, which is one of the largest kimberlite complexes in the Lac de Gras diamond field (over 1.5km in its longest dimension), the geophysical methods (ground gravity, EM and magnetics) highlighted obvious magnetic kimberlite phases drilled by previous explorers while also successfully defining a new kimberlite-like geophysical expression believed to have not yet been evaluated by drilling according to available public domain records. Previous drilling in the Jack Pine kimberlite complex has demonstrated it is significantly diamond bearing.
At the Suzanne kimberlite, ground geophysical work has revealed a magnetic low anomaly, a gravity anomaly and a linear EM anomaly interpreted to be over 600 meters in length. Data in the public domain indicates that only one drill hole tested this kimberlite leaving potentially untested kimberlite(s) and/or phases.
At the HL02 Kimberlite DeBeers drilled 2 long inclined holes one intersecting only a few meters of hypabyssal type kimberlite at the end of the hole. See Figure 2. It appears from this work that there is an untested gravity and EM target that breaks a diabase dyke. This is a classic compelling kimberlite drill target.
Figure 2. Top left Ohm Mapper results for the HL-02 Kimberlite. Colour image, EM data Magenta is less resistive. Contours Magnetic data. Dotted outlines depict drill target, Top Right Gravity Image, with Magnetic Contours, and bottom Left Magnetic image with EM Contours.
To view an enhanced version of Figure 2, please visit:
https://orders.newsfilecorp.com/files/4806/44557_arctic2.jpg
At the Kong Kimberlite shown in figure three is a double lobe magnetic anomaly drilled by Monopros however our work shows a distinct EM anomaly between the two lobes that has not be tested which could represent a new kimberlite or kimberlite phase.
Figure 3. Ohm Mapper 50m depth slice Resistivity results contours on the magnetic image for Kong East and West Kimberlites.
To view an enhanced version of Figure 3, please visit:
https://orders.newsfilecorp.com/files/4806/44557_10a1724c14e86a64_005full.jpg
At the Penelope Kimberlite target Figure 4 shows that there is an untested southern EM anomaly that could be caused by an untested kimberlite phase.
Figure 4. Ohm Mapper resistivity results 50m slice for the Penelope kimberlites suggests there is an untested kimberlite phase in the south. Black lines and dots depict drilling by earlier explorers.
To view an enhanced version of Figure 4, please visit:
https://orders.newsfilecorp.com/files/4806/44557_10a1724c14e86a64_006full.jpg
The company still has kimberlites that have not been covered by gravity and EM surveys, including the known, Anne, Tabatha, Finlay, Don, Drew, George, Emily, Don and Krista kimberlites. Given the high target generation success rate proven by our work to date, these remain a priority. This work can proceed at the same time as the planned drill program. It is important to note that the JV has obtained all the permits to conduct this drill program.
Qualified Person
The technical data in this news release has been reviewed and approved by Buddy Doyle, a diamond geologist with over 30 years of experience, a Qualified Person under the provisions of National Instrument 43-101.
About Arctic Star
The Company owns 100% of the recently acquired Timantti Diamond Project including a 1171 Ha Exploration Permit and a 193,700 Ha Exploration Reservation near the town of Kuusamo, in Finland. The project is located approximately 550km SW of the operating Grib Diamond Mine in Russia. Arctic has commenced its exploration in Finland on the Timantti Project, where four diamondiferous kimberlite bodies may represent the first finds in a large kimberlite field. The Company also controls diamond exploration properties in Nunavut (Stein) and the NWT (Diagras and Redemption).
Arctic Star has a highly experienced diamond exploration team previously responsible for several world class diamond discoveries.
ON BEHALF OF THE BOARD OF DIRECTORS OF
ARCTIC STAR EXPLORATION CORP.
“Patrick Power”
Patrick Power, President & CEO
+1 (604) 218-8772
ppower@arcticstar.ca
- Published in Arctic Star Exploration, Mining, News Home
Crop Completes Purchase of 1012 Acre Nevada Property With Newly Awarded Recreational Cannabis Licences
Momentum Public Relations
Press Release: May 6, 2019
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today it has completed the purchase of the suite of Recreational Cannabis licenses and the 1,012-acre property in its Elite Ventures Group 49% interest holding.
The total purchase price was $8,009,000 USD consisting of $4,058,100 amortized over 20 years for 843 acres of the real estate. CROP has paid $3,950,900 USD for 169 acres, including a down payment for the 20-year vendor financing for the remaining 843 acres. CROP has an option on all licenses once federally legal and will recoup 100% of its investment.
The State of Nevada has granted Recreational Adult Use Cultivation and Product Manufacturing and Distribution licenses for the company’s Esmeralda Cannabis Project. The company is currently constructing a wall around the 40-acre outdoor cannabis cultivation area for 2019 on the 1,012-acre property. The project requires an additional $250,000 in funding and, once complete, is expected to yield 80,000 pounds of +20% per year of THC, or approximately 15,000 KG of distillate, according to genetics readied for the project. Additionally, CBD/THC Extraction facilities will be constructed on the property in readiness for processing the 2019 crops.
The current market for extracted product in Nevada is approximately $20,000 per kg. of distillate, or approximately $1,000 per lb of outdoor flower according to the company’s tenant consultants.
CROP CEO, Michael Yorke, stated: “Closing this acquisition is the largest transaction CROP has ever completed to date. CROP now has the largest licensed recreational cannabis farm in the United States and perhaps the world with over 1,000 acres of which 40 acres will be planted this year.”
About CROP
Crop is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
Disclaimer for Forward-L
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
Nass Valley Gateway Enters into Letter of Intent with CSB Supply BV to Supply CBD Products for Distribution under Nass Valley’s Brand
Momentum Public Relations
Press Release: May 6, 2019
Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), trading on the Canadian Securities Exchange (“CSE”) under the trading Symbol “NVG” and on Deutsche Boerse Frankfurt under the trading Symbol 3NVN, is pleased to announce the signing of a letter of intent (“LOI”) with CSB Supply BV (“CSB”). CSB is a global business to business wholesale supplier of CBD (Cannabidiol) products.
Under the terms of the LOI CSB will supply and Nass Valley will market and distribute CBD products nationally in the United States and Canada under the Nass Valley brand.
CSB is headquartered in Amsterdam and has been in business for over 10 years manufacturing, packaging and whole-selling a variety of CBD products. The products supplied for Nass Valley’s brand will meet the US Federal legal requirements containing less than 0.3% THC (Tetrahydrocannabinol).
John Affenita, Nass Valley’s President & CEO, commented: “We are very excited to be entering into this LOI with a prominent and well established CBD manufacturing company that meets the required quality and specification for Nass Valley’s brand. The full range of products will be available for us to sell and distribute nationally and internationally. We believe that this partnership will be financially beneficial to both parties.”
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: “NVG”; Frankfurt: “3NVN”) is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. (“PTI”) which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol (“THC”) content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited (“ABL”).
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept of its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jerseyoperations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
View original content:http://www.prnewswire.com/news-releases/nass-valley-gateway-enters-into-letter-of-intent-with-csb-supply-bv-to-supply-cbd-products-for-distribution-under-nass-valleys-brand-300843842.html
- Published in CBD, Life Sciences, Nass Valley Gateway, News Home
Canada Cobalt Appoints New Director
Momentum Public Relations
Press Release: May 3, 2019
Canada Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (the “Company” or “Canada Cobalt”) is pleased to announce the appointment of Mr. Marc T. Bamber to the Company’s Board of Directors, effective immediately.
Mr. Bamber, based in London, England, has nearly two decades of successful deal-making experience in the capital markets, with a primary focus on the resource sector, and will use his international connections to help spearhead an aggressive corporate development strategy pertaining to Canada Cobalt’s proprietary Re-2OX Process (refer to April 30, 2019, news release).
“Given the latest results, Dr. Molnar and SGS Lakefield have taken Re-2OX to an exciting new level that opens new doors of opportunity for Canada Cobalt and its shareholders, not only in Northern Ontario but on a global scale,” stated Bamber. “I look forward to playing an important role in leveraging this technology into much more of a key value-driver for Canada Cobalt among a series of positive catalysts for the company.”
Mr. Bamber was a core member of an award-winning special situations fund for 7 years, vetting and executing investments in hundreds of resource, tech, media and food companies.
About Canada Cobalt Works Inc.
Canada Cobalt is focused on immediate and longer-term value drivers at its past producing Castle mine and adjoining land package in the historic Northern Ontario Silver-Cobalt district, Canada’s cobalt heartland since the start of the electric vehicle revolution. The Canada Cobalt “advantage” includes underground access at Castle, an innovative tailings program with a plan to recover silver, gold and cobalt, a recently installed pilot plant to produce gravity concentrates on site, a proprietary hydrometallurgical process known as Re-2OX, and exciting exploration discovery potential at Castle East.
“Frank J. Basa”
Frank J. Basa, P. Eng.
President and Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.
SOURCE Canada Cobalt Works Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2019/03/c2539.html
Contact:
Frank J. Basa, P.Eng., President and CEO, 1-819-797-4144; or Wayne Cheveldayoff, Corporate Communications, waynecheveldayoff@gmail.com, 1-416-710-2410
- Published in Canada Cobalt Works, Mining, News Home
Arctic Star grants options to buy 1.18 million shares
Momentum Public Relations
Press Release: May 3, 2019
ARCTIC STAR ANNOUNCES AMENDMENT TO GRANT OF STOCK OPTIONS
Arctic Star Exploration Corp., further to its news release dated March 21, 2019, wishes to correct the number of options granted on that date from an aggregate of 3.45 million stock options to an aggregate of 2.9 million options granted at an exercise price of eight cents per share. Today, the company announces that it has granted an additional 1.18 million stock options to its directors, employees and consultants for the purchase of up to 1.18 million common shares of the company pursuant to its stock option plan. Each option is exercisable for a period of five years at a price of nine cents per common share.
- Published in Arctic Star Exploration, Mining, News Home
Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study
Momentum Public Relations
Press Release: May 2, 2019
Panag Pharma Inc. (Panag), a subsidiary of Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX-V: TBP) (OTCQB: TBPMF), today announced that its pilot clinical study to evaluate the tolerability and potential efficacy of its PPP003 ophthalmic drug in the treatment of indolent corneal ulcers in companion animals has been authorized by the Veterinary Drugs Directorate (VDD), Health Canada. VDD granted the Experimental Studies Certificate to the veterinary ophthalmologists that will be performing the clinical study for Panag.
“Panag has developed a series of cannabinoid-based drugs for the pharmaceutical market,” stated Dr. Melanie Kelly, Co-Founder, Panag Pharma. “Over the last year, we have worked with Tetra to develop an ophthalmic pipeline for pain and inflammatory conditions of the eye. PPP003 is one of the most important assets in our ophthalmic portfolio.”
“PPP003 is a new chemical entity which, in addition to patent protection, would benefit from 6 years data exclusivity plus 2 years marketing exclusivity granted under the Canadian drug regulations,” said Dr. Guy Chamberland, CEO and CSO of Tetra Bio-Pharma. “This product candidate comes from our collaboration with Panag. The granting of this authorization by VDD further reinforces the importance of our recent acquisition and our ability to meet milestones.”
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada authorized, and FDA reviewed, clinical trials aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabinoids and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
For more information visit: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
About Panag Pharma:
Panag Pharma Inc. is a Canadian based bio-tech company focused on the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Panag believes that pain relief should be safe, non-addictive and above all; effective. The Panag Pharma team of PhD scientists and medical doctors are among the world’s leading researchers and clinicians in pain treatment and management. They bring a combined experience of over 100 years in research and clinical care of people dealing with chronic pain and inflammatory conditions. Panag’s current pipeline of pain relief products include formulations for the topical application to the skin, the eye and other mucous membranes. Recently approved by Health Canada and currently undergoing clinical trials, Panag Pharma’s Topical AOTC provides a new approach to the treatment of chronic pain and inflammation.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, including the success of PPP003 and its other drug candidates, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process including the applications for Orphan Drug Designation, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tetra Bio-Pharma Contact:
Guy Chamberland, Ph.D.,
Chief Executive Officer and Chief Scientific Officer
514-220-9225
Investors@tetrabiopharma.com
Investor Contact:
Pierre Boucher, CPA, CMA
Partner, Executive Vice-President
514-731-000 ext. 237
Investors@tetrabiopharma.com
Media Contact:
Energi PR
Carol Levine, APR, FCPRS
514-288-8500 ext. 226
Carol.levine@energipr.com
- Published in Life Sciences, Medical Marijuana, News Home, Tetra Bio Pharma
Nass Valley Announces Changes to Board of Directors
Momentum Public Relations
Press Release: May 2, 2019
Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), announces that it has accepted the resignation of Dr. Samuel Alawieh as Director and COO of the Company and its Subsidiary Advanced Bioceuticals Limited (“ABL”) for personal reasons, effective April 26, 2019. Nass Valley acknowledges Dr. Alawieh’s contributions especially in ABL and wishes him the best with his future endeavours.
Nass Valley also wishes to announce the planned resignation of Milo Filgas as Director of the Company and its Audit Committee. Mr. Filgas’ resignation is conditional upon the CSE acceptance of the “Personal Information Form” submitted by the newly nominated board member and highly qualified independent member of the Audit Committee. The Company would also thank Mr. Filgas for his contributions and is looking forward to continue working with him as a member of its Advisory Committee.
The Company’s President and CEO, Mr. John Peter Affenitacommented, “We will announce the new appointments to the Board very shortly and I am convinced that with the industry leading knowledge of its new team members Nass Valley will be well positioned to meet the challenges of its planned vertical integration within the CBD sector and the growing needs of our customers”.
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: “NVG”; Frankfurt: “3NVN”) is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. (“PTI”) which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol (“THC”) content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited (“ABL”).
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept tof its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jerseyoperations internationally.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
We seek Safe Harbor.
SOURCE Nass Valley Gateway Ltd.
View original content: http://www.newswire.ca/en/releases/archive/May2019/02/c0174.html
- Published in CBD, Nass Valley Gateway, News Home
ATW Tech Renews Contract with RAMQ
Momentum Public Relations
Press Release: May 2, 2019
ATW Tech Inc (“ATW Tech” or the “Company”) (TSX-V: ATW) announces that its division VuduMobile has renewed its contract with Régie d’assurance maladie du Québec (“RAMQ”) for an additional year without changing the amount, terms, and conditions.
RAMQ, the government health insurance board in Quebec, has integrated VuduMobile’s text messaging solution as part of its effort to better serve familial medical clinics across the province with the governmental program Rendez-Vous Santé Québec (rsvq.gouv.qc.ca).
“I am delighted that RAMQ continues to trust in VuduMobile as a strategic communication partner. Our team strives to always provide great products and exceptional service, and every retained customer is a reaffirmation that we are on the right track,” said Ghislain Dallaire, Vice President and General Manager of the VuduMobile division.
Additional information regarding ATW Tech is available on SEDAR at www.sedar.com.
The TSX Venture Exchange and its Regulatory Services provider (as per meaning assigned to this term in TSX Venture Exchange’s policies) bear no liability as to the relevance or accuracy of this press release.
ABOUT ATW TECH
ATW Tech is a leader in financial technologies (‘fintech’), owner of several web platforms including VoxTel, VuduMobile, Option.vote and Bloomed. VoxTel offers various interactive communication, landline and mobile carrier billing phone solutions. VuduMobile is specialized in text messaging for enterprises through its unique, user-friendly and bilingual text messaging application and turnkey solutions. Option.vote offers a large scale, customizable, and secure multi-method voting system for unions, political parties, professional associations, and others looking for a way to reduce their voting costs and to improve their participation rates. Bloomed is a cloud-based platform to manage data (smart data) on consumers and their behaviors which is developed for marketing agencies and their campaigns for the consumer and corporate markets.
SOURCE:
ATW TECH Michel Guay Founder, president and CEO Tel.: 844.298.5932 ext. 301 mguay@atwtech.com www.atwtech.com |
Simon Bédard, CA, CPA, CFA, MBA Chief Financial Officer Tel.: 844.298.5932 ext. 304 sbedard@atwtech.com |